Description

ANARIDEX 1 is a highly effective anti-cancer therapy designed for postmenopausal women diagnosed with hormone receptor-positive breast cancer. It contains Anastrozole 1mg, a potent aromatase inhibitor that lowers estrogen levels in the body by blocking the enzyme aromatase, which converts androgens into estrogen.

This action is crucial in slowing or halting the growth of estrogen-dependent breast cancer cells. ANARIDEX 1 is often used as:

• First-line treatment for postmenopausal women with advanced breast cancer

• Adjuvant therapy following surgery or radiation

• A follow-up therapy after tamoxifen in some treatment plans

ANARIDEX 1 is well-tolerated, easy to administer, and supported by global clinical guidelines.

Manufactured in WHO-GMP, ISO 9001:2015, and FDA-export compliant pharmaceutical environments, ANARIDEX 1 is a dependable oncology product for regulated and semi-regulated markets.

Presented by BLUEPILL EXPRESS, your trusted partner in the global export of specialty pharmaceuticals.

• Active Ingredient: Anastrozole 1mg

• Therapeutic Category: Oncology / Hormone Therapy

• Primary Indication: Hormone receptor-positive breast cancer in postmenopausal women

• Dosage Form: Oral Tablet

• Mode of Action: Aromatase Inhibition (Estrogen reduction)

• Certifications: WHO-GMP | ISO 9001:2015 | FDA-export compliant

• Exporter: BLUEPILL EXPRESS

How to Use:

Take one tablet (1mg) once daily at the same time each day. May be taken with or without food. Continue treatment as directed by an oncologist or healthcare professional.